The map’s signal reflects where an inhaled tracer reaches within the lungs. Regions receiving less gas, aerosol, or another ventilation tracer produce reduced representation, while uneven distribution creates regional contrasts. This spatial pattern converts a measurement of tracer distribution into a functional view that can reveal localized airflow impairment even when the clinical question concerns the lungs as a whole.
A reduced signal indicates that less ventilation tracer reached a region, but it does not by itself identify the cause. The pattern may be considered in relation to airway obstruction, chronic lung disease, or another process that changes regional airflow. Interpretation therefore depends on the distribution of abnormal areas and comparison with complementary imaging when available.
Comparing ventilation with perfusion helps identify mismatched abnormalities, in which airflow and blood-flow patterns do not correspond. This comparison adds functional context that a ventilation image alone cannot provide and is particularly relevant when clinicians evaluate conditions such as pulmonary embolism. The combined pattern can help distinguish the significance of regional abnormalities during clinical interpretation.
Structural imaging shows anatomical changes, whereas ventilation defect maps add information about how air reaches different lung regions. Using both perspectives can connect an observed structural abnormality with its functional effect or reveal regional impairment that requires separate explanation. This complementary approach supports a more complete assessment of pulmonary disease and localized lung dysfunction.
Production begins by measuring how an inhaled gas, aerosol, or other ventilation tracer distributes through the lungs. The measured distribution is then displayed spatially, with areas of reduced signal indicating comparatively limited tracer delivery. Clinicians may evaluate the resulting map alone or alongside perfusion images, depending on the diagnostic question and available examination.
Clinicians may use these maps when regional airflow information is important for evaluating pulmonary embolism, airway obstruction, chronic lung disease, or other conditions that alter ventilation. Their value lies in localizing functional impairment rather than only describing overall pulmonary status. The findings can complement structural imaging and help organize interpretation of disease-related abnormalities.
Because the maps localize regional ventilation abnormalities, repeated assessments can help clinicians examine whether the distribution or extent of impaired airflow changes over time. This provides a functional comparison that may complement other clinical or imaging information. Monitoring regional patterns can therefore support evaluation of evolving pulmonary disease and changes in lung function.